Medical Training AIAdvanced Dyslipidemia Management
You'll be able to work up and manage complex lipid disorders, from interpreting advanced lipid panels to selecting and sequencing therapy for high-risk and treatment-resistant patients.
What this track covers
This track covers advanced lipid management beyond first-line statin therapy: lipoprotein metabolism and atherogenesis, risk stratification with tools like CAC scoring, and treatment selection for familial hypercholesterolemia, statin intolerance, and severe hypertriglyceridemia. It also covers newer non-statin agents and how they fit alongside established therapies.
What you will practice
- Interpreting a lipid panel beyond LDL, including apoB and Lp(a) when relevant
- Estimating ASCVD risk and applying risk enhancers to adjust treatment thresholds
- Working through statin intolerance and choosing an alternative or add-on strategy
- Recognizing features suggestive of familial hypercholesterolemia and next steps
- Sequencing non-statin therapies for patients not at goal on maximally tolerated statin
Simulator scenario
A patient with a strong family history of early cardiovascular disease and a markedly elevated LDL presents for evaluation, requiring risk assessment and a stepwise treatment plan.
Board question topics
- ASCVD risk calculation and use of risk enhancers
- Statin intolerance evaluation and management
- Diagnostic criteria for familial hypercholesterolemia
- Approach to severe hypertriglyceridemia
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free